Tracking the XCEM expected move helps you see how far Columbia EM Core ex-China ETF's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Columbia EM Core ex-China ETF's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the XCEM expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For XCEM, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The XCEM expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Columbia EM Core ex-China ETF is unlikely to go.
The fund will invest at least 80% of its net assets in the companies included in the index and the advisor generally expects to be substantially invested at such times, with at least 95% of its net assets invested in these securities. The index is designed to provide broad, core emerging markets equity exposure by measuring the stock performance of up to 700 emerging markets companies, excluding companies domiciled or exchange-listed in China or domiciled in Hong Kong. It is non-diversified.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the XCEM expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Columbia EM Core ex-China ETF expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about XCEM.
